NEW YORK, Sept. 27, 2011 /PRNewswire/ -- Kinerase, an icon of scientific skincare development, continues to provide award winning beauty for the second year in a row. The Kinerase Restructure Firming Eye Cream has been named a winner in the 2011 Allure Best of Beauty Awards, appearing in the magazine's October 2011 issue.
This year, over 236 beauty products were chosen as winners across a number of categories, including skincare, hair care, cosmetics and tools. Winners were selected by Allure's editors and other industry leaders, trying thousands of products before awarding the top honors. The winning products -- which will boast the coveted Allure Best of Beauty seal of approval -- were honored by Allure at an awards ceremony Thursday night (9.15.11) at New York's Jazz at Lincoln Center.
KINERASE RESTRUCTURE FIRMING EYE CREAM:
A departure from the typical firming products, Kinerase Restructure Firming Eye Cream ($59 available at Ulta, Ulta.com, Nordstrom or Kinerase.com) visibly transforms skin by targeting elastin protein coils to lift and tone the contours of the eye area.
This luxurious Kinerase eye firming regimen combines the plant extract LOXL Stimulator, potent, clinically proven antioxidants and .15% Kinetin to improve skin elasticity and tone, tighten, and restructure for a more lifted look. Restructure Firming Eye Cream also reduces the appearance of expression wrinkles and deeply moisturizes for firmer, smoother, more youthful-looking skin.
KINERASE® skincare provides powerful anti-aging efficacy, delivering clinically-proven visible results in gentle skin-caring formulations. The power behind Kinerase is Kinetin (N6-furfuryladenine), a plant-based antioxidant whose anti-aging properties were discovered when scientists found that it prevented plant leaves from drying out and withering. With Kinerase, indulge the luxury of skincare science to reveal youthful, radiant skin. For more information visit http://www.kinerase.com or https://www.facebook.com/#!/Kinerase
About Valeant Pharmaceuticals International, Inc.
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. More information about Valeant Pharmaceuticals International, Inc. can be found at www.valeant.com.
Copyright©2010 PR Newswire.
All rights reserved